Skip to main content

Table 5 Diagnostic performances of interleukin 6 and hepatocyte growth factor and conventional markers in predicting severe acute pancreatitis in all patients ( N = 163) a

From: Circulating cytokines in predicting development of severe acute pancreatitis

Predictive marker with optimal cutoff point

AUC

Sensitivity (%)

Specificity (%)

LR+

LR-

DOR

IL-6 (>501.6 pg/ml)

0.81 (0.72 to 0.90)

48.0 (30.0 to 66.5)

93.5 (88.1 to 96.5)

7.4 (3.5 to 15.6)

0.56 (0.38 to 0.81)

13.2 (4.7 to 37.3)

HGF (>3,020.1 pg/ml)

0.87 (0.81 to 0.94)

60.0 (40.7 to 0.77)

92.8 (87.1 to 96.0)

8.3 (4.2 to 16.3)

0.43 (0.27 to 0.70)

19.2 (6.9 to 53.6)

IL-6 + HGF

0.89 (0.82 to 0.96)

72.0 (52.4 to 85.7)

89.9 (83.7 to 93.9)

7.1 (4.1 to 12.3)

0.31 (0.17 to 0.59)

22.8 (8.1 to 64.0)

CRP (>227 mg/L)

0.692 (0.57 to 0.82)

40.0 (23.4 to 59.3)

93.5 (88.0 to 96.5)

6.1 (2.8 to 13.6)

0.64 (0.47 to 0.89)

9.6 (3.4 to 27.2)

Creatinine (>141 μmol/L)

0.76 (0.65 to 0.88)

40.0 (23.4 to 59.3)

96.3 (91.7 to 98.4)

10.9 (4.1 to 29.1)

0.62 (0.45 to 0.86)

17.5 (5.3 to 57.9)

Calcium (<1.91 mmol/L)

0.81 (0.70 to 0.91)

57.9 (36.3 to 76.9)

93.2 (87.6 to 96.4)

8.5 (4.1 to 17.8)

0.45 (0.27 to 0.77)

18.8 (6.0 to 58.4)

  1. aIL, interleukin; CRP, C-reactive protein; IL, interleukin; HGF, Hepatocyte growth factor; IL, Interleukin; AUC, Area under curve; DOR, Diagnostic odds ratio; LR-, Negative likelihood ratio; LR+, Positive likelihood ratio; 95% confidence intervals are given in parentheses.